These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 30084485)
1. Epigenetics of fragile X syndrome and fragile X-related disorders. Kraan CM; Godler DE; Amor DJ Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567 [TBL] [Abstract][Full Text] [Related]
4. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients. Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181 [TBL] [Abstract][Full Text] [Related]
5. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays. Sølvsten C; Nielsen AL Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618 [TBL] [Abstract][Full Text] [Related]
6. Methylated premutation of the FMR1 gene in three sisters: correlating CGG expansion and epigenetic inactivation. Tabolacci E; Pomponi MG; Remondini L; Pietrobono R; Nobile V; Pennacchio G; Gurrieri F; Neri G; Genuardi M; Chiurazzi P Eur J Hum Genet; 2020 May; 28(5):567-575. PubMed ID: 31804632 [TBL] [Abstract][Full Text] [Related]
7. microRNAs and Fragile X Syndrome. Lin SL Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181 [TBL] [Abstract][Full Text] [Related]
8. DNA Methylation, Mechanisms of Nobile V; Pucci C; Chiurazzi P; Neri G; Tabolacci E Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669384 [TBL] [Abstract][Full Text] [Related]
9. Establishment of FXS-A9 panel with a single human X chromosome from fragile X syndrome-associated individual. Nakayama Y; Adachi K; Shioda N; Maeta S; Nanba E; Kugoh H Exp Cell Res; 2021 Jan; 398(2):112419. PubMed ID: 33296661 [TBL] [Abstract][Full Text] [Related]
11. Human pluripotent stem cell models of Fragile X syndrome. Bhattacharyya A; Zhao X Mol Cell Neurosci; 2016 Jun; 73():43-51. PubMed ID: 26640241 [TBL] [Abstract][Full Text] [Related]
12. Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Brouwer JR; Mientjes EJ; Bakker CE; Nieuwenhuizen IM; Severijnen LA; Van der Linde HC; Nelson DL; Oostra BA; Willemsen R Exp Cell Res; 2007 Jan; 313(2):244-53. PubMed ID: 17150213 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Jacquemont S; Curie A; des Portes V; Torrioli MG; Berry-Kravis E; Hagerman RJ; Ramos FJ; Cornish K; He Y; Paulding C; Neri G; Chen F; Hadjikhani N; Martinet D; Meyer J; Beckmann JS; Delange K; Brun A; Bussy G; Gasparini F; Hilse T; Floesser A; Branson J; Bilbe G; Johns D; Gomez-Mancilla B Sci Transl Med; 2011 Jan; 3(64):64ra1. PubMed ID: 21209411 [TBL] [Abstract][Full Text] [Related]
14. CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full Mutations. Brykczynska U; Pecho-Vrieseling E; Thiemeyer A; Klein J; Fruh I; Doll T; Manneville C; Fuchs S; Iazeolla M; Beibel M; Roma G; Naumann U; Kelley N; Oakeley EJ; Mueller M; Gomez-Mancilla B; Bühler M; Tabolacci E; Chiurazzi P; Neri G; Bouwmeester T; Di Giorgio FP; Fodor BD Stem Cell Reports; 2016 Dec; 7(6):1059-1071. PubMed ID: 27840045 [TBL] [Abstract][Full Text] [Related]
16. Site-specific R-loops induce CGG repeat contraction and fragile X gene reactivation. Lee HG; Imaichi S; Kraeutler E; Aguilar R; Lee YW; Sheridan SD; Lee JT Cell; 2023 Jun; 186(12):2593-2609.e18. PubMed ID: 37209683 [TBL] [Abstract][Full Text] [Related]
17. Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome. Colak D; Zaninovic N; Cohen MS; Rosenwaks Z; Yang WY; Gerhardt J; Disney MD; Jaffrey SR Science; 2014 Feb; 343(6174):1002-5. PubMed ID: 24578575 [TBL] [Abstract][Full Text] [Related]
18. Maternal FMR1 premutation allele expansion and contraction in fraternal twins. Alfaro MP; Cohen M; Vnencak-Jones CL Am J Med Genet A; 2013 Oct; 161A(10):2620-5. PubMed ID: 23949867 [TBL] [Abstract][Full Text] [Related]
19. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome. Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684 [TBL] [Abstract][Full Text] [Related]
20. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons. Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]